Parametric Portfolio Associates’s Lexicon Pharmaceuticals LXRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
$108K Sell
51,724
-32,611
-39% -$90.4K ﹤0.01% 3553
2021
Q4
$332K Buy
84,335
+5,537
+7% +$26.9K ﹤0.01% 3243
2021
Q3
$379K Sell
78,798
-7,048
-8% -$28.9K ﹤0.01% 3209
2021
Q2
$394K Sell
85,846
-6,855
-7% -$33K ﹤0.01% 3176
2021
Q1
$544K Sell
92,701
-4,207
-4% -$29.1K ﹤0.01% 3461
2020
Q4
$331K Buy
96,908
+42,424
+78% +$80.9K ﹤0.01% 3555
2020
Q3
$78K Buy
54,484
+3,466
+7% +$6.17K ﹤0.01% 3830
2020
Q2
$102K Sell
51,018
-6,120
-11% -$12K ﹤0.01% 3783
2020
Q1
$111K Buy
57,138
+35,108
+159% +$105K ﹤0.01% 3711
2019
Q4
$91K Buy
22,030
+7,833
+55% +$30.2K ﹤0.01% 3872
2019
Q3
$43K Buy
14,197
+478
+3% +$1.48K ﹤0.01% 3904
2019
Q2
$86K Sell
13,719
-3,876
-22% -$23.2K ﹤0.01% 3856
2019
Q1
$98K Sell
17,595
-1,010
-5% -$6.13K ﹤0.01% 3820
2018
Q4
$124K Sell
18,605
-78,951
-81% -$640K ﹤0.01% 3758
2018
Q3
$1.04M Sell
97,556
-9,914
-9% -$114K ﹤0.01% 3068
2018
Q2
$1.29M Buy
107,470
+32,475
+43% +$332K ﹤0.01% 2925
2018
Q1
$643K Buy
74,995
+34,710
+86% +$321K ﹤0.01% 3226
2017
Q4
$398K Buy
+40,285
New +$419K ﹤0.01% 3440
2017
Q3
Sell
-11,066
Closed -$182K 4041
2017
Q2
$182K Buy
+11,066
New +$171K ﹤0.01% 3840
2017
Q1
Sell
-10,840
Closed -$150K 3801
2016
Q4
$150K Buy
+10,840
New +$174K ﹤0.01% 3658
2016
Q3
Sell
-93,039
Closed -$1.33M 3792
2016
Q2
$1.33M Buy
93,039
+2,024
+2% +$27.5K ﹤0.01% 2622
2016
Q1
$1.09M Buy
91,015
+78,480
+626% +$823K ﹤0.01% 2862
2015
Q4
$167K Sell
12,535
-4,281
-25% -$52.6K ﹤0.01% 3774
2015
Q3
$181K Buy
+16,816
New +$184K ﹤0.01% 3115
2014
Q4
Sell
-1,618
Closed -$16K 3996
2014
Q3
$16K Buy
+1,618
New +$17.3K ﹤0.01% 3802
2014
Q2
Sell
-2,066
Closed -$25K 3766
2014
Q1
$25K Sell
2,066
-293
-12% -$3.74K ﹤0.01% 3806
2013
Q4
$30K Buy
+2,359
New +$37.5K ﹤0.01% 3802

Other funds holding LXRX